Managing opioid withdrawal precipitated by buprenorphine with buprenorphine.

Drug Alcohol Rev

Drug and Alcohol Services, South East Sydney Local Health District, Sydney, Australia.

Published: May 2021

Buprenorphine is a partial opioid agonist commonly used to treat opioid dependence. The pharmacology of buprenorphine increases the risk of a precipitated opioid withdrawal when commencing patients on buprenorphine treatment, particularly when transferring from long acting opioids (e.g. methadone). There is little documented experience regarding the management of precipitated withdrawal. In our case, a patient developed a significant precipitated opioid withdrawal following buprenorphine administration, and was able to be successfully treated in hospital with further buprenorphine. This demonstrates that rapid increases in buprenorphine dose can be used as an effective treatment for buprenorphine-induced precipitated opioid withdrawal. The use of buprenorphine to manage withdrawal then allows the individual to continue on this highly effective treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248003PMC
http://dx.doi.org/10.1111/dar.13228DOI Listing

Publication Analysis

Top Keywords

opioid withdrawal
16
precipitated opioid
12
buprenorphine
9
buprenorphine buprenorphine
8
withdrawal buprenorphine
8
effective treatment
8
withdrawal
6
precipitated
5
opioid
5
managing opioid
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!